CXCL10 and malaria: For patients with severe malaria (n = 84), as defined according to the adjusted WHO criteria [13], [14], there were significantly increased levels of IL-8, IP-10 and MIP-1β compared with the patients with uncomplicated malaria (n = 45) (Table 3).